[1]
D. Inoue, H. Maruoka, and T. Takahashi, “CLINICAL ANALYSIS AND OPTIMIZATION OF POST-REMISSION THERAPY FOR ACUTE MYELOID LEUKEMIA PATIENTS WITH MINIMAL RESIDUAL DISEASE AS DETERMINED BY FLOW CYTOMETRY”, MJHID, vol. 2, no. 2, p. e2010020, Aug. 2010.